Electromagnetic therapies span TENS, microcurrent, PEMF, and Rife. The proven core is PEMF, FDA-approved for non-union fractures since 1979 with growing evidence in osteoarthritis and post-surgical pain; microcurrent adds RCT support for wound healing. The contested fringe is frequency-specific and Rife-style claims, which the entry treats as unproven.
Summary drafted from this entry’s sources; editorial review pending.
01Key questions
Does PEMF actually work?
For bone healing, yes, FDA-approved for non-union fractures since 1979 with studies reporting 30–40% faster healing. Evidence is moderate for knee osteoarthritis pain and post-surgical pain.
What is the difference between TENS and microcurrent?
TENS uses felt milliamp currents for symptom relief via pain-gate mechanics. Microcurrent uses sub-sensory microamp currents framed as reparative, and its wound-healing RCT evidence is real; neither proves structural healing from analgesia alone.46
Is Rife therapy legitimate?
No. The entry calls pathogen-destruction frequency claims unproven and bordering on pseudoscience, with no credible evidence.
What does the evidence say about consumer PEMF devices?
Mixed. Device marketing has outpaced evidence for most marketed indications; the entry sees a defensible role only for medically supervised PEMF in bone indications.
Core thesis: Electromagnetic fields — when properly applied at specific frequencies and intensities — can non-invasively stimulate cellular healing, reduce pain, accelerate bone repair, and modulate inflammation. FDA-approved for non-union fractures since 1979, PEMF and related modalities have growing evidence for broader applications.
02Overview of Electromagnetic Modalities
| Modality | Frequency Range | Mechanism | FDA Status |
|---|---|---|---|
| PEMF | 1-100 Hz | Pulsed field → cellular membrane signaling | Approved (bone healing) |
| TENS | 1-250 Hz | Transcutaneous nerve stimulation → pain gate | OTC approved |
| Microcurrent (MENS) | 0.1-1000 μA | Mimics endogenous current → ATP production | Research |
| PEMF High-intensity | 1-50 Hz, high Gauss | Deep tissue penetration | Off-label |
| Frequency-specific microcurrent | Specific frequency pairs | Tissue-specific resonance (contested) | Research |
| Rife therapy | Specific RF frequencies | Pathogen destruction (unproven) | Not approved |
Swipe table →
03Pulsed Electromagnetic Field Therapy (PEMF)
Mechanism of Action
- Faraday's law: Changing magnetic fields induce electrical currents in conductive tissue
- Cellular membrane effects: Induced current modifies membrane potential → alters ion channel function
- Calcium signaling: PEMF increases intracellular Ca2+ → activates calmodulin → downstream healing cascades
- ATP production: Increased mitochondrial membrane potential → enhanced energy production
- Growth factor release: Stimulates VEGF, BMP-2, FGF release
- Anti-inflammatory: Modulates NF-κB signaling, reduces pro-inflammatory cytokines
FDA-Approved Indications
- Non-union fractures (since 1979) — strong evidence
- Post-operative edema and pain (specific devices)
- Cervical fusion adjunct
Clinical Evidence
Bone Healing (Strong)
- PEMF is FDA-approved for non-union fractures — one of the strongest evidence bases
- Accelerates fracture healing by 30-40% in many studies
- Stimulates osteoblast proliferation and differentiation
- PMID: PMC7434032 — "PEMF is a safe and effective treatment for non-unions"
Osteoarthritis (Moderate)
- PMID 38610722 (2024): "PEMF demonstrated positive outcomes across various anatomical districts, primarily in knee osteoarthritis"
- Reduces pain and improves function in knee OA
- May have disease-modifying effects (cartilage preservation)
Soft Tissue Healing (Moderate)
- PMID 19371845 — "PEMF used successfully in management of postsurgical pain, chronic wounds, and vasodilation"
- Accelerates wound healing, especially in diabetic patients
- Reduces post-surgical pain and edema
Pain Management (Moderate)
- Effective for chronic musculoskeletal pain
- May reduce need for analgesic medications
- Mechanism: endorphin release, nerve membrane stabilization
Neurological Applications (Emerging)
- Depression: TMS (transcranial magnetic stimulation) is FDA-approved for treatment-resistant depression
- Traumatic brain injury: Early research on PEMF for TBI recovery
- Neuropathy: Some evidence for diabetic neuropathy symptom relief
Uses
| Parameter | Range in the literature | Notes |
|---|---|---|
| Frequency | 1-50 Hz | Different frequencies for different tissues |
| Intensity | 1-50 Gauss (low-intensity) | Up to 2000 Gauss for high-intensity devices |
| Duration | 20-60 min per session | Varies by condition |
| Treatment course | 2-12 weeks | Bone healing: 3-6 months |
Swipe table →
Notable PEMF Devices
- OMPulse / MG-33: Clinical-grade PEMF
- MAS PEMF: High-intensity full-body systems
- Bemer: Low-intensity, consumer-grade
- Ondamed: Frequency-specific PEMF system
- Hugo: High-intensity, affordable
04Transcutaneous Electrical Nerve Stimulation (TENS)
Mechanism
- Gate control theory: Non-painful electrical input closes the "gate" to painful input at spinal cord level
- Endorphin release: High-frequency TENS triggers endogenous opioid release
- Does not heal tissue — purely symptomatic pain relief
Evidence
- Moderate evidence for chronic musculoskeletal pain
- Moderate evidence for neuropathic pain
- Inconsistent evidence — responder vs. non-responder patterns
- Best used as adjunct, not standalone
05Microcurrent Therapy (MENS) and FSM
See also: Frequency-Specific Microcurrent for a full deep-dive.
Mechanism
- Extremely low current (microamperes) — usually below sensory threshold
- Mimics or augments endogenous bioelectric currents involved in wound repair
- May influence membrane potential, calcium flux, ATP demand, nitric oxide signaling, and local perfusion
- ATP/protein synthesis claims usually trace to Cheng et al. (1982); useful mechanistic signal, but preclinical rather than proof of clinical efficacy
- Promotes wound healing at cellular level when parameters and tissue context are appropriate
Evidence
- Wound healing: Moderate RCT/meta-analysis evidence. A 2022 meta-analysis of RCTs found greater wound area reduction and shorter healing time when electrical microcurrent was added to standard wound care (PMID 34903470).
- Palatal surgical wounds: Double-masked RCT found faster closure/epithelialization and less early pain after free gingival graft harvest (PMID 32783220).
- Delayed-onset muscle soreness: Small frequency-specific microcurrent RCT reported large reductions in post-eccentric-exercise soreness versus untreated control leg (PMID 20538225).
- FSM (Frequency-Specific Microcurrent): Contested. Uses paired frequencies claimed to target tissue/pathology combinations. Pilot data and clinician reports are interesting, but the specific-frequency hypothesis remains less proven than generic microcurrent wound-healing effects.
Practical Parameters
| Parameter | Range in the literature | Notes |
|---|---|---|
| Current | ~10–1,000 μA | More is not necessarily better; often sub-sensory. |
| Session length | 20–60 min | Acute DOMS study used 20 min; clinical FSM often longer. |
| Delivery | electrodes, wet towels, graphite gloves | Skin contact and hydration affect current delivery. |
| Best-supported use | wound-healing adjunct | Especially when objective wound size can be tracked. |
Swipe table →
Cautions
Avoid unsupervised use with implanted electrical devices, pregnancy over abdomen/pelvis, seizure history when treating near head/neck, or wounds/infections requiring medical care. Treat broad claims about curing chronic infections, cancer, or systemic disease as unproven until replicated in controlled trials.
06Critical Analysis
What's Real
- PEMF for bone healing is firmly established and FDA-approved
- PEMF for pain/inflammation has growing evidence
- TENS for pain is a reasonable non-pharmacological option
- Microcurrent has biological plausibility and wound healing evidence
What's Questionable
- Rife therapy: Claims that specific RF frequencies destroy pathogens. No credible evidence. This borders on pseudoscience.
- Frequency-specific healing claims: The idea that specific frequencies target specific tissues is not well-established
- Cancer treatment claims: No evidence that electromagnetic therapies cure cancer
- Miracle cure marketing: Many PEMF devices are marketed with exaggerated claims
Why Conventional Medicine Resists
- Electromagnetic therapy challenges the pharmaceutical paradigm
- Insurance rarely covers these therapies
- Medical education doesn't include bioelectromagnetics
- The field has been polluted by pseudo-scientific marketing
07Practical Notes
Conservative Selection Framework
- Bone non-union or fusion adjunct: prioritize medically supervised PEMF with device parameters and orthopedic follow-up.
- Pain-only goal: TENS may be sufficient and cheaper; do not infer structural healing from analgesia.
- Wound-healing adjunct: microcurrent has a stronger evidence base than most “frequency medicine” claims; track wound area and healing time objectively.
- Soft tissue recovery: consider PEMF, microcurrent, Overview - Photobiomodulation, loading progression, and Peptide Therapy for Injuries as separate variables rather than adding everything at once.
Safety Cautions
Avoid casual use over implanted electrical devices, pregnancy over abdomen/pelvis, active malignancy without oncology approval, open wounds unless the protocol/device is wound-specific, or infections requiring medical care. Device marketing often exceeds evidence; prefer published parameters and objective endpoints.
08Notes
- PEMF has the strongest conventional/regulatory foothold in bone-healing applications.
- Microcurrent has surprisingly decent wound-healing evidence but the exact clinical parameters remain heterogeneous.
- FSM is promising enough to track but not mature enough to treat its frequency tables as established physiology.
- Future expansion: split PEMF, TENS, microcurrent, and FSM into separate notes if this section becomes device/protocol-heavy.
09Connections
10Sources
- Shupak NM et al. (2003). "PEMF Stimulation of Bone Healing." PMC7434032PMC7434032
- further R et al. (2024). "Current Evidence Using PEMF." PMID 38610722PubMed 38610722
- Markov MS. (2015). "Evidence-Based Use of PEMF Therapy." PMID 19371845PubMed 19371845
- Poltawski L et al. (2022). "Electrical microcurrent stimulation therapy for wound healing: A meta-analysis of randomized clinical trials." PMID 34903470 .PubMed 34903470
- PubMed 32783220PubMed 32783220
- Curtis D et al. (2010). "The efficacy of frequency specific microcurrent therapy on delayed onset muscle soreness." PMID 20538225 .PubMed 20538225
11Entry history
Latest content update.
Heretic informs and never prescribes. Where amounts appear, they describe what published studies used. Talk to a qualified clinician before acting on anything here.